Compounding and Compounding Pharmacies - Pharmacy Technician Pulse

Projection Estimates GLP-1 Market to Nearly Double by End of Decade | Asembia 2025

Drug Topics

MAY 1, 2025

Although the market is expected to continue to become more popular, compounding pharmacies will no longer be allowed to manufacture these medications, as shortages have been listed as resolved.

Compounding Pharmacies

Compounding Pharmacies Compounding

What is compounded semaglutide made of?

The Checkup by Singlecare

JANUARY 9, 2025

Due to the rising demand for weight loss drugs and the resulting drug shortages , some specialized compounding pharmacies make compounded semaglutide injections. Compounded versions of semaglutide contain varying ingredients, and theyre not approved by the U.S. There are a few times when compounding is necessary.

Compounding

Compounding Compounding Pharmacies FDA Sterile Compounds

What to know before buying compounded semaglutide online

The Checkup by Singlecare

JANUARY 15, 2025

Compounded semaglutide is another option, and its lower cost may make it seem like an appealing alternative. Compounded drugs can feel like a reprieve from shortages, insurance denials, or high prices. Heres what you need to know before you buy compounded semaglutide online, according to experts. What are compounding pharmacies?

Compounding

Compounding Compounding Pharmacies FDA Dosage

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

STAT

DECEMBER 19, 2024

The agency said it would give these compounders a grace period of 60 to 90 days before enforcing rules that would put a halt to their work, in an effort to avoid disruption for patients.

Compounding

Compounding FDA Compounding Pharmacies

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT

APRIL 29, 2025

The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options. Businesses are changing prescriptions, mixing in additives, or encouraging stockpiling of existing compounded products. Some have disappeared altogether.

Compounding

Compounding Compounding Pharmacies FDA

FDA issues warnings to GLP-1 compounders

The Checkup by Singlecare

DECEMBER 19, 2024

As a result, the use of medications like Ozempic , Wegovy , Zepbound , Rybelsus , and Mounjaro has skyrocketed, as people turned to these medications to help them lose weightcausing drug shortages and creating a market for compounded versions of these brand-name drugs. RELATED: Is compounded semaglutide safe? But the U.S.

Compounding

Compounding FDA Labelling Compounding Pharmacies

Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide

Fierce Pharma

OCTOBER 23, 2024

The war is on between compounding pharmacies making knockoff versions of popular weight loss drugs and pharma giants Novo Nordisk and Eli Lilly, who want to protect their right to sell their patent | Novo Nordisk has asked the FDA to prevent compounders from manufacturing copycat versions of its juggernaut diabetes and obesity treatments Ozempic and (..)

Compounding

Compounding Compounding Pharmacies FDA

STAT+: Court ruling opens door to FDA action against Ozempic compounders

STAT

APRIL 25, 2025

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. Compounding pharmacies are legally allowed to make versions of branded treatments if the drugs are deemed to be in shortage by the FDA.

Compounding

Compounding Compounding Pharmacies FDA

STAT+: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

STAT

OCTOBER 30, 2024

Over the past two years, patients seeking treatment have been turning to compounding pharmacies, which make cheaper copies of branded treatments and are legally allowed to do so only when the branded treatments are listed on the FDA’s shortage list. Continue to STAT+ to read the full story…

Compounding Pharmacies

Compounding Pharmacies Compounding FDA

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

Pharmacy Times

OCTOBER 25, 2024

The call follows the FDA’s sudden removal of tirzepatide from the drug shortage list, preventing compounding pharmacies from providing the drug.

Compounding Pharmacies

Compounding Pharmacies Compounding FDA

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

Pharmacy Times

APRIL 4, 2025

Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.

Compounding Pharmacies

Compounding Pharmacies Compounding

Are Compounding Pharmacies Safe? Everything You Need to Know

Compounding Pharmacy of America

DECEMBER 23, 2024

Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

Compounding Pharmacies Market Caters To Key Regional Health Care Issues

Pharmacy Times

JULY 18, 2022

Pharmacists can leverage patient medical history for formulating effective drugs, and patients can also benefit from single dosage, greater efficacy, and affordability of compounded medications.

Compounding

Compounding Compounding Pharmacies Dosage

Independent Pharmacist on Navigating the Dynamic Pharmacy Profession

Drug Topics

NOVEMBER 26, 2024

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.

Compounding Pharmacies

Compounding Pharmacies Independent Pharmacies Compounding

Q&A: How a Community Pharmacist is Helping Other Pharmacies Through Consulting

Drug Topics

NOVEMBER 25, 2024

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, joined Drug Topics to discuss his career journey.

Compounding Pharmacies

Compounding Pharmacies Compounding

An Independent Pharmacist’s Journey to Championing Community Care

Drug Topics

OCTOBER 9, 2024

Drug Topics sat down with Benjamin Jolley, PharmD, of Jolley’s Compounding Pharmacy, to discuss the pharmacy industry and his experience in a myriad of roles within the profession.

Compounding Pharmacies

Compounding Pharmacies Compounding

5 Proven Strategies for Growing Your Compounding Pharmacy

DiversifyRx

MARCH 24, 2023

The interest in compounding has definitely increased recently. Use these 5 proven strategies to grow your compounding prescriptions and profits. I love compounding. It was my first passion in pharmacy. For me, every potential compounding patient is a problem that needs solving.

Compounding Pharmacies

Compounding Pharmacies Compounding Independent Pharmacies

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

PharmaVoice

DECEMBER 11, 2024

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies continue their lucrative operations for now.

Compounding

Compounding Compounding Pharmacies FDA

Diabetes and Compounded Medications: A Personalized Approach to Chronic Care

Compounding Pharmacy of America

MAY 27, 2025

Discover how compounded medications offer custom support for diabetes, neuropathy, and hormone balance. The post Diabetes and Compounded Medications: A Personalized Approach to Chronic Care appeared first on Compounding Pharmacy of America. Tailored care for better results.

Compounding

Compounding Compounding Pharmacies

Don’t Ignore Erectile Dysfunction

Compounding Pharmacy of America

DECEMBER 6, 2024

Addressing ED is not just about improving […] The post Dont Ignore Erectile Dysfunction appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT

OCTOBER 22, 2024

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. The FDA still has to make a decision on whether to officially place semaglutide on the lists.

Compounding

Compounding Compounding Pharmacies FDA Documentation

FDA Affirms Decision on Tirzepatide Shortage Resolved, Sets Transition Period for Compounding

Pharmacy Times

DECEMBER 20, 2024

Compounding pharmacies have a 60- to 90-day grace period to complete production as it continues to monitor supply and demand.

Compounding

Compounding Compounding Pharmacies FDA

STAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

STAT

MARCH 5, 2025

Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs.

Compounding Pharmacies

Compounding Pharmacies Compounding Insurance

FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs

Fierce Pharma

DECEMBER 19, 2024

The agencys move means that compounding pharmacies will have to halt production of their knockoff versions of diabetes drug Mounjaro and obesity treatment Zepbound. The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. |

Compounding Pharmacies

Compounding Pharmacies FDA Compounding

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

MAY 15, 2023

At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary guidance allowing traditional compounding pharmacies, within tight regulatory guardrails, to prepare 13 Covid drugs from pure ingredients to meet hospitals’ urgent need.

Compounding Pharmacies

Compounding Pharmacies Compounding Hospitals FDA

STAT+: FDA and large compound pharmacies settle a long-running dispute over a key list for ingredients

STAT

OCTOBER 12, 2022

Food and Drug Administration and a trade group that represents large compound pharmacies have resolved a long-running dispute over the use of bulk ingredients, clearing the way for some compounded medicines to become available more quickly. Continue to STAT+ to read the full story…

Compounding Pharmacies

Compounding Pharmacies Compounding FDA

Compounded semaglutide with B12: Benefits and risks

The Checkup by Singlecare

MARCH 31, 2025

However, due to the shortage, compounding pharmacies and facilities were allowed to temporarily produce compounded semaglutide to meet the high demandeven though compounded semaglutide injections are not FDA approved. Some facilities add B12 to their compounds, in addition to semaglutide.

Compounding

Compounding Compounding Pharmacies FDA Adverse Reactions

Compounded semaglutide side effects

The Checkup by Singlecare

FEBRUARY 17, 2025

Many people are turning to compounded versions of semaglutide for various reasons, such as costs and shortages of approved medications like Ozempic and Wegovy. While compounding alternatives might seem appealing, they lack the testing and quality control of their approved counterparts. Is compounded semaglutide safe?

Compounding

Compounding Compounding Pharmacies FDA Dosage

STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro

STAT

SEPTEMBER 20, 2023

As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding

Compounding Compounding Pharmacies

Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list

Fierce Pharma

OCTOBER 8, 2024

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, claiming its action to remove Eli Lilly’s Mounjaro and Zepbound from its drug shortage list is a “reckless and arbitrary decision—lacking any semblance of lawful process.”

Compounding

Compounding Compounding Pharmacies FDA

STAT+: Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy

STAT

OCTOBER 6, 2023

judge dismissed its lawsuit accusing a compound pharmacy of selling versions of its Wegovy and Ozempic medicines, which are widely prescribed for weight loss and have become franchise products for the drug company. The drug maker argued the compounders were selling versions of its medicines that were never approved by the U.S.

Compounding

Compounding Compounding Pharmacies

FDA rethinking block on compounding of Lilly's obesity drug

pharmaphorum

OCTOBER 14, 2024

Faced with lawsuit, FDA rethinks block on compounding pharmacies making Eli Lilly's diabetes and obesity drug tirzepatide

Compounding

Compounding Compounding Pharmacies FDA

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

STAT

FEBRUARY 25, 2025

… Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the company seeks to draw patients away from cheap, compounded copies of weight loss medications , STAT reports. Pharmacy compounders sued the U.S.

Compounding

Compounding FDA Compounding Pharmacies Communication

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

pharmaphorum

OCTOBER 23, 2024

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.

Compounding

Compounding Compounding Pharmacies FDA

Proper Use of Automation in Hazardous Drug Compounding Pharmacies

Pharmacy Times

JANUARY 16, 2024

Although robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.

Compounding Pharmacies

Compounding Pharmacies Compounding

Comprehensive Nationwide Compounding Pharmacy Services

Compounding Pharmacy of America

JANUARY 2, 2025

Learn about our compounding pharmacy services and shipping areas. The post Comprehensive Nationwide Compounding Pharmacy Services appeared first on Compounding Pharmacy of America. Serving patients across the U.S. with custom medications tailored to your needs.

Compounding Pharmacies

Compounding Pharmacies Compounding

Will compounded semaglutide be banned?

The Checkup by Singlecare

JANUARY 13, 2025

A compounded medication is a custom formulation of an existing brand-name or generic drug made by a licensed pharmacist and designed to meet a patients unique needs. For example, a person who is allergic to a common dye included in a prescription drug could have a compounded version of the drug made without that dye.

Compounding

Compounding Compounding Pharmacies FDA Insurance Coverage

STAT+: Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

STAT

OCTOBER 8, 2024

A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list.

Compounding

Compounding FDA Compounding Pharmacies

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT

MARCH 20, 2025

Food and Drug Administration wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies that have fueled widespread use of the knockoffs have other plans , The Wall Street Journal writes. And some pharmacies making the GLP-1 drug copycats will continue.

Compounding Pharmacies

Compounding Pharmacies Compounding Dosage FDA

Beyond one-size-fits-all: How compounding pharmacies address allergies with precision

pharmaphorum

JUNE 7, 2024

Discover how compounding pharmacies use genetic information to create precision medications tailored to individual allergies. Learn how personalised treatments can benefit you.

Compounding Pharmacies

Compounding Pharmacies Compounding

5 Reasons to Use a Compounding Pharmacy

Compounding Pharmacy of America

DECEMBER 23, 2024

Discover five key reasons to choose a compounding pharmacy, from personalized medications to allergy-free formulations and tailored solutions for unique needs. The post 5 Reasons to Use a Compounding Pharmacy appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

Should Pharmacies Keep Compounding GLP1s?

DiversifyRx

APRIL 29, 2025

Should You Keep Compounding GLP1s (Tirzepatide or Semaglutide) After the FDA Deadline? Howdy pharmacy peeps… Lets have a real talk about compounding GLP1s. These compounds have been huge revenue drivers and powerful tools for helping patients lose weight and improve metabolic health. Here’s My Take.

Compounding

Compounding Sterile Compounds FDA Compounding Pharmacies

STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

STAT

OCTOBER 11, 2024

The Food and Drug Administration on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, from its shortage list, and, for the time being, would not pursue regulatory action against certain compounding pharmacies making copies of the drugs.

Compounding Pharmacies

Compounding Pharmacies FDA Compounding

How Compounding Pharmacies Help Seniors Easily Manage Prescriptions

Compounding Pharmacy of America

DECEMBER 26, 2024

Discover how compounding pharmacies provide custom solutions for seniors, improving medication adherence, reducing side effects, and enhancing quality of life. The post How Compounding Pharmacies Help Seniors Easily Manage Prescriptions appeared first on Compounding Pharmacy of America.

Compounding Pharmacies

Compounding Pharmacies Compounding

Projection Estimates GLP-1 Market to Nearly Double by End of Decade | Asembia 2025

What is compounded semaglutide made of?

Trending Sources

What to know before buying compounded semaglutide online

STAT+: FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

FDA issues warnings to GLP-1 compounders

Novo Nordisk asks FDA to prevent compounders from making copycat versions of GLP-1 star semaglutide

STAT+: Court ruling opens door to FDA action against Ozempic compounders

STAT+: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

Are Compounding Pharmacies Safe? Everything You Need to Know

Compounding Pharmacies Market Caters To Key Regional Health Care Issues

Independent Pharmacist on Navigating the Dynamic Pharmacy Profession

Q&A: How a Community Pharmacist is Helping Other Pharmacies Through Consulting

An Independent Pharmacist’s Journey to Championing Community Care

5 Proven Strategies for Growing Your Compounding Pharmacy

GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?

Diabetes and Compounded Medications: A Personalized Approach to Chronic Care

Don’t Ignore Erectile Dysfunction

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

FDA Affirms Decision on Tirzepatide Shortage Resolved, Sets Transition Period for Compounding

STAT+: Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price

FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT+: FDA and large compound pharmacies settle a long-running dispute over a key list for ingredients

Compounded semaglutide with B12: Benefits and risks

Compounded semaglutide side effects

STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro

Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list

STAT+: Judge dismisses Novo Nordisk lawsuit over compounded versions of Ozempic and Wegovy

FDA rethinking block on compounding of Lilly's obesity drug

STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

Proper Use of Automation in Hazardous Drug Compounding Pharmacies

Comprehensive Nationwide Compounding Pharmacy Services

Will compounded semaglutide be banned?

STAT+: Compounding group sues FDA for removing Lilly’s obesity drug from its shortages list

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

Beyond one-size-fits-all: How compounding pharmacies address allergies with precision

5 Reasons to Use a Compounding Pharmacy

Should Pharmacies Keep Compounding GLP1s?

STAT+: In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list

How Compounding Pharmacies Help Seniors Easily Manage Prescriptions

Stay Connected